Yusuf Henriques

US Army Veteran, Founder & CEO of IndyGeneUs Health Group and sister company IndyGeneUs AI, a Service-Disabled Veteran-Owned Small Business (SDVOSB) genomics company creating the world’s largest block-chain encrypted repository of indigenous and diasporic African clinical and multi-omics genetic data to drive precision health equity globally. Prior to starting IndyGeneUs AI, Mr. Henriques is the founder of Polaris Genomics (formerly known as TruGenomix Health Inc.), a Service-Disabled Veteran-Owned Small Business (SDVOSB) precision genomics behavioral health company harnessing the power of genomics to improve risk prediction and diagnosis of Post-Traumatic Stress Disorder (PTSD). The PTSD genomic assay (TruGen-1) that was developed under his executive leadership using exclusive patented technology provided by Icahn School of Medicine at Mount Sinai (ISMMS) and Max Planck Institute (MPI) and is now being validated at the Department of Veteran Affairs (VA) hospitals nationwide to address the high rate of suicides in the veteran and active-duty population. He led investor relations which yielded a 2M seed capital raise in 2020. www.polarisgenomics.com